Nachrichten zur GSK PLC Aktie

GSK: Zantac-Klagen - Belastungen in Milliardenhöhe? Aktienanalyse

Kulmbach (www.aktiencheck.de) - GSK-Aktienanalyse von "Der Aktionär": Marion Schlegel vom Anlegermagazin "Der Aktionär" nimmt die Aktie von GSK plc (ISIN: GB00BN7SWP63,…

GSK: Zantac litigation obscures the positives, says leading investment bank

Deutsche Bank has maintained its "buy" rating on GSK PLC (LSE:GSK, NYSE:GSK) despite the recent setback in the Zantac litigation as…

GSK: Zantac litigation obscures the positives, says leading investment bank

Deutsche Bank has maintained its "buy" rating on GSK PLC (LSE:GSK, NYSE:GSK) despite the recent setback in the Zantac litigation as…

GSK shares plunge after US judge rules Zantac cases can go to trial

GSK PLC (LSE:GSK, NYSE:GSK) lost over £6 billion in market value after court judge in the US state of Delaware allowed more…

GSK to appeal US judges Zantac ruling, shares plunge

GSK PLC (LSE:GSK, NYSE:GSK) lost over £6 billion in market value after court judge in the US state of Delaware allowed more…

GSK shares plunge after US judge rules Zantac cases can go ahead

GSK PLC (LSE:GSK, NYSE:GSK) lost over £6 billion in market value after court judge in the US state of Delaware allowed more…

GSK to appeal US judges Zantac ruling

GSK PLC (LSE:GSK, NYSE:GSK) says it disagrees with a decision by a court judge in the US state of Delaware who…

GSK shares plunge after US judge rules Zantac cases can go to trial

GSK PLC (LSE:GSK, NYSE:GSK) lost over £6 billion in market value after court judge in the US state of Delaware allowed more…

GSK plc: Long-Term Cash Cow

…

GSK found not guilty in Zantac trial

British pharmaceuticals big cap GSK PLC (LSE:GSK, NYSE:GSK) has won a high-stake personal injury case in the state of Illinois,…

GSK found not guilty in Zantac trial

British pharmaceuticals big cap GSK PLC (LSE:GSK, NYSE:GSK) has won a high-stake personal injury case in the state of Illinois,…

GSK: Zantac settlement could reach $2bn, says investment bank

GSK PLC (LSE:GSK, NYSE:GSK) may face a settlement of up to $2 billion to resolve thousands of lawsuits related to…

GSK: Moderate Bewertung trotz Kursanstieg - Aktienanalyse

Wien (www.aktiencheck.de) - GSK-Aktienanalyse von der Raiffeisen Bank International AG: Raphael Schicho, Analyst der Raiffeisen Bank International AG (RBI), stuft die…

GSK confirms Haleon exit for total of £3.9 billion

GSK PLC (LSE:GSK, NYSE:GSK) confirmed it has raised a total of £3.9 billion through the exit of its stake in…

GSK confirms exit of Haleon stake for £3.9 billion

GSK PLC (LSE:GSK, NYSE:GSK) confirmed it has raised a total of £3.9 billion through the exit of its stake in…

GSK plc (GSK) Q1 2024 Earnings Call Transcript

…

GSK beginning to alleviate long-held concerns, say analysts

GSK PLC (LSE:GSK, NYSE:GSK) is approaching 18-month highs after the pharma groups boss Emma Walmsley raised the full-year outlook on the…

Pharmahersteller GSK erhöht Gewinnziel für 2024

LONDON (dpa-AFX) - Der Pharmakonzern GSK ist besser als erwartet in das neue Jahr gestartet.…

GSK Q1 beats consensus and FY numbers upgraded after vaccines boost

GSK PLC (LSE:GSK, NYSE:GSK) has confirmed what recent prescription data hinted at: Its vaccines business is firing on all cylinders.…

The Global Market for HPV Associated Disorders, 2018-2023 and 2024-2033, Featuring Profiles of Leading Players AstraZeneca, Roche, Biocon, GlaxoSmithKline, and Merck & Co

Dublin, April 19, 2024 (GLOBE NEWSWIRE) -- The "HPV Associated Disorders Global Market Report 2024" report has been…

Global CAR T-Cell Therapy Market Size To Worth USD 21.92 Billion By 2033 | CAGR of 17.72%

The Global CAR T-Cell Therapy Market Size was Valued at USD 4.29 Billion in 2023 and the Worldwide CAR T-Cell…

GSK Follows Rivals, to Cap Out-of-Pocket Inhaler Cost in US

GSK plc (GSK) plans to lower the prices of its entire inhaled respiratory products to $35 per month in the…

ANALYSE-FLASH: Jefferies belässt GSK auf 'Buy' - Ziel 1950 Pence

NEW YORK (dpa-AFX Broker) - Das Analysehaus Jefferies hat die Einstufung für GSK auf "Buy"…

GSK plc (GSK) TD Cowen 44th Annual Health Care Conference (Transcript)

…

GSK: Has Blenreps blockbuster status been restored?

GSK PLC (LSE:GSK, NYSE:GSK) cancer discovery Blenreps blockbuster potential has been reawakened, according to Shore Capital. The broker was commenting...…

GSK boss sees pay jump 51% in 2023

GSK PLC (LSE:GSK, NYSE:GSK) boss Emma Walmsley saw her overall pay rise 51% to around £13 million in 2023 after…

GSK settles another Zantac lawsuit in California

GSK PLC (LSE:GSK, NYSE:GSK) has confidentially settled a lawsuit in California that claimed its now-discontinued heartburn medication, Zantac, caused...…

GSK settles another California lawsuit

GSK PLC (LSE:GSK, NYSE:GSK) has confidentially settled a lawsuit in California that claimed its now-discontinued heartburn medication, Zantac, caused...…

Antisense and RNAi Therapeutics Market Size & Share Envisaged To Reach USD 18.43 Billion By 2032, at 17.8% CAGR Growth: Polaris Market Research

The global Antisense and RNAi Therapeutics Market size and share is currently valued at USD 4.34 billion in 2023. It…

GSK plc: An Undervalued Vaccine Behemoth That Is Resuming Growth; Buy

…

GSK: American investment bank goes positive on the stock for the first time in seven years. Heres why

The healthcare team at Citi has turned positive on GSK PLC (LSE:GSK, NYSE:GSK) for the first time in seven years.…

Gummy Market to surpass $51 Bn by 2032, Says Global Market Insights Inc.

Major gummy market participants include Nestle SA, Bayer AG, Church & Dwight Co. Inc, Procter & Gamble, Unilever PLC (OLLY),…

GSK agrees another Zantac settlement in California

GSK PLC (LSE:GSK, NYSE:GSK) has reached a confidential settlement regarding a lawsuit in California, which accused its discontinued heartburn medication,...…

GSK plc (GSK) Q4 2023 Earnings Call Transcript

…

ROUNDUP: Pharmahersteller GSK will auch 2024 mehr verdienen - Aktie legt zu

LONDON (dpa-AFX) - Der Pharmakonzern GSK rechnet nach einem Ergebnis- und Umsatzplus im vergangenen Jahr…

GSK plc 2023 Q4 - Results - Earnings Call Presentation

…

Pharmahersteller GSK will auch 2024 mehr verdienen - optimistischer für Zukunft

LONDON (dpa-AFX) - Der Pharmakonzern GSK rechnet nach einem Ergebnis- und Umsatzplus im vergangenen Jahr…

GSK: Im Norden nichts Neues - Aktienanalyse

Wien (www.aktiencheck.de) - GSK-Aktienanalyse von der Raiffeisen Bank International AG: Raphael Schicho, Analyst der Raiffeisen Bank International AG (RBI), nimmt die…

GSK, Novo Nordisk, interest rates and Boeing: Day Ahead on Wednesday

Followers of big pharma are likely to be keen to hear from GSK PLC (LSE:GSK, NYSE:GSK) and Novo Nordisk (NYSE:NVO) on Wednesday, while…

GSK, Novo Nordisk, interest rates and Boeing: Day Ahead on Wednesday

Followers of big pharma are likely to be keen to hear from GSK PLC (LSE:GSK, NYSE:GSK) and Novo Nordisk (NYSE:NVO) on Wednesday, while…

GSK RSV vaccine achieves blockbuster status in just over six months

GSK PLC has seen its RSV vaccines shoot to blockbuster status in little over six months, according to the Financial Times…

GSK: Coverage aufgenommen

New York (www.aktiencheck.de) - Rating-Update: Mark Purcell, Analyst von Morgan Stanley, nimmt die Coverage der Aktie von GSK plc. (ISIN: GB00BN7SWP63,…

GSK nets £978m from Haleon share sale

GSK PLC (LSE:GSK, NYSE:GSK) said it completed the sale of 300 million shares in Haleon, the consumer health giant, netting…

GSK and AstraZeneca: an upgrade and a downgrade from this investment bank

UBS has revised its stance on two major UK-listed pharma companies – GSK PLC (LSE:GSK, NYSE:GSK) and AstraZeneca PLC (LSE:AZN) – with…

GSK and AstraZeneca: an upgrade and a downgrade from this investment bank

UBS has revised its stance on two major UK-listed pharma companies – GSK PLC (LSE:GSK, NYSE:GSK) and AstraZeneca PLC (LSE:AZN) – with…

Is GSK worth £20 a share? This broker seems to thinks so

Shore Capitals recent research note on GSK PLC (LSE:GSK, NYSE:GSK) paints an optimistic picture for the pharmaceutical giant, underlining reasons…

GSK plc (GSK) 42nd Annual JP Morgan Healthcare Conference (Transcript)

…

GSK: Eine beeindruckende Performance - Die Aktie bleibt ein Value-Pick - Aktienanalyse

Wien (www.aktiencheck.de) - GSK-Aktienanalyse von der Raiffeisen Bank International AG: Raphael Schicho, Analyst der Raiffeisen Bank International AG (RBI), rät in…

GSK strong finish expected, says Barclays

GSK PLC (LSE:GSK, NYSE:GSK) should deliver better than expected fourth-quarter results on January 31, according to Barclays, amid heightened expectations...…

GSK to pay up to US$1.4bn for respiratory acquisition

GSK PLC (LSE:GSK, NYSE:GSK) has moved to bolster its respiratory pipeline with the acquisition of Aiolos Bio for up to US$1.4 billion.…